Gilead Sciences | Stock



Stock Veränderung Datum
AbbVie USD 4.53B 345M 2025-03
Agios Pharmaceuticals USD 30.85M 1.24M 2025-06
ALKERMES USD 191.92M 8.49M 2025-06
Alnylam Pharmaceuticals USD 71.69M 6.11M 2025-06
Amgen USD 6.58B 146M 2025-06
Biogen USD 2.27B 400K 2025-06
BioMarin Pharmaceutical USD 1.27B 42.2M 2025-03
Bristol-Myers Squibb USD 2.74B 71M 2025-06
Eli Lilly USD 11.01B 1.7B 2025-06
Gilead Sciences USD 1.76B 1.83B 2025-03
GlaxoSmithKline GBP 6.07B 72M 2025-06
Glaxosmithkline 5.67B 249M 2024-12
Incyte USD 83.42M 19.45M 2025-06
J&J USD 12.66B 215M 2025-03
Merck USD 6.6B 405M 2025-06
Moderna USD 240M 112M 2025-06
Neurocrine Biosciences USD 56.9M 2.2M 2025-06
Novartis USD 6.31B 478M 2025-06
Pfizer USD 10.85B 1000K 2025-03
PTC Therapeutics USD 34.06M 12.39M 2025-06
Regeneron Pharmaceuticals USD 3.21B 760.7M 2025-06
Sanofi EUR 9.62B 12.23B 2025-06
Sarepta Therapeutics USD 994.04M 52.6M 2025-06
United Therapeutics USD 169.2M 3.8M 2025-06
Vertex Pharmaceuticals USD 1.36B 154.3M 2025-03


Gilead Sciences Stock - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.